These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14097208)

  • 41. [Effect of ergotamine tartrate on the normal electrocardiogram].
    RODRIGUEZ MI
    Arch Col Med El Salv; 1949 Sep; 2(3):153-76. PubMed ID: 15393999
    [No Abstract]   [Full Text] [Related]  

  • 42. Thin-layer chromatography of lysergide and other ergot alkaloids.
    Fowler R; Gomm PJ; Patterson DA
    J Chromatogr; 1972 Oct; 72(2):351-7. PubMed ID: 5076795
    [No Abstract]   [Full Text] [Related]  

  • 43. Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects.
    PETERS GA; HORTON BT
    Proc Staff Meet Mayo Clin; 1951 Apr; 26(9):153-61. PubMed ID: 14827944
    [No Abstract]   [Full Text] [Related]  

  • 44. Headache; with special reference to the excessive use of ergotamine tartrate and dihydroergotamine.
    PETERS GA; HORTON BT
    J Lab Clin Med; 1950 Dec; 36(6):972-3. PubMed ID: 14795057
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical pharmacokinetics of ergotamine, dihydroergotamine, ergotoxine, bromocriptine, methysergide, and lergotrile.
    Kanto J
    Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):135-42. PubMed ID: 6133838
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Chromatographic isolation and direct spectrofluorimetric determination on the chromatogram of microgram amounts of drugs. V. Study of liquids, tablets and suppositories containing ergometrine and ergotamine].
    Frijns JM
    Pharm Weekbl; 1971 Nov; 106(47):865-81. PubMed ID: 5139825
    [No Abstract]   [Full Text] [Related]  

  • 47. [Xanthic derivatives inhibiting the inversion by ergotamine of the hypotensor effects of isopropyladrenaline and of 3-4-dioxyephedrine].
    HAZARD R; BEAUVALLET M; GIUDICELLI R
    C R Seances Soc Biol Fil; 1951 Jan; 145(1-2):78-80. PubMed ID: 14839877
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effects of caffeinated ergotamine tartrate in migraine attacks (E. C. 110 or cafergon); first results].
    GIRARD M
    Lyon Med; 1950 May; 183(22):345-8. PubMed ID: 15438042
    [No Abstract]   [Full Text] [Related]  

  • 49. Activity of 6-methyl-8-substituted ergolines against the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma.
    Sweeney MJ; Poore GA; Kornfeld EC; Bach NJ; Owen NV; Clemens JA
    Cancer Res; 1975 Jan; 35(1):106-9. PubMed ID: 1109784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of migraine and persistent headache with ergotamine tartrate and novocaine aerosols].
    TABART J
    Presse Med (1893); 1950 Nov; 58(76):1351-2. PubMed ID: 14797654
    [No Abstract]   [Full Text] [Related]  

  • 51. Headache as seen by the otolaryngologist with special reference to the use of cafergone-E.C. 110 ergotamine tartrate and caffeine for the relief of attacks.
    HILSINGER RL
    Christ Hosp Med Bull; 1949 Apr; 2(4):85-93. PubMed ID: 18130723
    [No Abstract]   [Full Text] [Related]  

  • 52. [Inversion by ergotamine of hypotensive action of small doses of adrenalin in the dog].
    HAZARD R; BEAUVALLET M; GIUDICELLI R
    C R Seances Soc Biol Fil; 1951 Apr; 145(7-8):564-5. PubMed ID: 14859591
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effects of ergotamine tartrate-caffeine in migraine attacks (EC 110 cafergon); first results].
    GIRARD M
    Arch Mal Appar Dig Mal Nutr; 1950; 39(9-10):1016-21. PubMed ID: 14790963
    [No Abstract]   [Full Text] [Related]  

  • 54. Alkaloid binding and activation of D2 dopamine receptors in cell culture.
    Larson BT; Harmon DL; Piper EL; Griffis LM; Bush LP
    J Anim Sci; 1999 Apr; 77(4):942-7. PubMed ID: 10328360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparative investigations on the effect of gynergen and hydergin on the electrocardiogram; contribution on possible applicability of the ergot test].
    ZEH E
    Z Kreislaufforsch; 1950 Nov; 39(21-22):675-84. PubMed ID: 14789117
    [No Abstract]   [Full Text] [Related]  

  • 56. Gastric secretagogue action of ergot alkaloids in the perfused stomach of anesthetized rats.
    Maeda-Hagiwara M; Watanabe K
    Eur J Pharmacol; 1982 Apr; 79(1-2):105-10. PubMed ID: 7084301
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of associated acetylcholine-atropine and acetylcholine-ergotamine on essential hypotension].
    RIVASI P
    Rass Neurol Veg; 1950 Jun; 8(2):138-49. PubMed ID: 14781409
    [No Abstract]   [Full Text] [Related]  

  • 58. Variability in the content and composition of alkaloids found in Canadian ergot. I. Rye.
    Young JC
    J Environ Sci Health B; 1981; 16(1):83-111. PubMed ID: 6894157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A NEW METHOD OF ISOLATING ERGOMETRINE].
    FANG QC
    Yao Xue Xue Bao; 1963 Dec; 10():712-9. PubMed ID: 14098712
    [No Abstract]   [Full Text] [Related]  

  • 60. Experiences with di-hydro-ergotamine in the treatment of primary uterine inertia.
    GILL RC; FARRAR JM
    J Obstet Gynaecol Br Emp; 1951 Feb; 58(1):79-91. PubMed ID: 14804193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.